VOMERO, SALVATORE
 Distribuzione geografica
Continente #
NA - Nord America 6.548
EU - Europa 5.076
AS - Asia 2.980
SA - Sud America 522
AF - Africa 106
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 6
Totale 15.246
Nazione #
US - Stati Uniti d'America 6.474
GB - Regno Unito 1.318
CN - Cina 1.209
RU - Federazione Russa 839
SG - Singapore 832
IE - Irlanda 670
UA - Ucraina 488
DE - Germania 483
SE - Svezia 467
BR - Brasile 436
FR - Francia 330
HK - Hong Kong 241
VN - Vietnam 237
IT - Italia 209
KR - Corea 177
FI - Finlandia 139
IN - India 83
TR - Turchia 39
ES - Italia 38
AR - Argentina 33
CA - Canada 32
ZA - Sudafrica 28
CI - Costa d'Avorio 25
IQ - Iraq 25
MX - Messico 25
BD - Bangladesh 24
ID - Indonesia 19
NG - Nigeria 17
EC - Ecuador 16
JP - Giappone 14
NL - Olanda 14
BE - Belgio 13
CZ - Repubblica Ceca 12
PL - Polonia 11
AE - Emirati Arabi Uniti 9
AZ - Azerbaigian 9
CO - Colombia 9
CL - Cile 8
KE - Kenya 8
MA - Marocco 8
RO - Romania 8
UZ - Uzbekistan 8
PK - Pakistan 7
PY - Paraguay 7
AT - Austria 6
CR - Costa Rica 6
EE - Estonia 6
EU - Europa 6
JO - Giordania 6
NP - Nepal 6
PH - Filippine 6
DZ - Algeria 5
LT - Lituania 5
SA - Arabia Saudita 5
VE - Venezuela 5
AU - Australia 4
EG - Egitto 4
KZ - Kazakistan 4
NZ - Nuova Zelanda 4
TN - Tunisia 4
UY - Uruguay 4
HN - Honduras 3
PE - Perù 3
PT - Portogallo 3
TH - Thailandia 3
AL - Albania 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
KG - Kirghizistan 2
LK - Sri Lanka 2
NI - Nicaragua 2
SN - Senegal 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
CG - Congo 1
CV - Capo Verde 1
DK - Danimarca 1
IR - Iran 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LI - Liechtenstein 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
Totale 15.242
Città #
Southend 1.171
Fairfield 816
Dallas 786
Dublin 668
Singapore 502
Ashburn 454
Jacksonville 403
Woodbridge 357
Chandler 349
Santa Clara 339
Wilmington 318
Seattle 286
Cambridge 269
Beijing 252
Houston 246
Hefei 238
Moscow 232
Hong Kong 230
Ann Arbor 188
Seoul 176
Princeton 156
Nanjing 136
San Jose 119
Los Angeles 92
Siena 87
Ho Chi Minh City 80
Lauterbourg 71
Hanoi 68
Fremont 67
Boardman 63
The Dalles 63
Helsinki 49
Nanchang 49
Shenyang 46
Buffalo 42
Munich 42
Bengaluru 40
San Diego 40
New York 38
Shanghai 37
São Paulo 37
Dearborn 36
Lancaster 32
Düsseldorf 28
Hebei 28
Málaga 28
Abidjan 25
Tianjin 25
Izmir 22
Menlo Park 22
Norwalk 22
Orem 22
San Mateo 22
Frankfurt am Main 20
Jiaxing 20
Jinan 20
Johannesburg 20
San Francisco 19
Changsha 18
Kunming 18
London 18
Venezia 18
Mestre 17
Stockholm 17
Redwood City 16
Philadelphia 15
Washington 15
Zhengzhou 14
Rio de Janeiro 13
Belo Horizonte 11
Brussels 11
Toronto 11
Abuja 10
Haiphong 10
Turku 10
Atlanta 9
Baghdad 9
Curitiba 8
Milan 8
Ningbo 8
Rome 8
Tokyo 8
Baku 7
Brasília 7
Brno 7
Brooklyn 7
Campinas 7
Guangzhou 7
Mexico City 7
Montreal 7
Mumbai 7
Ottawa 7
Quito 7
Redondo Beach 7
Ribeirão Preto 7
Tashkent 7
Amman 6
Amsterdam 6
Ankara 6
Biên Hòa 6
Totale 10.535
Nome #
Design, Synthesis, and Biological Evaluation of Imidazo[1,5-a]quinoline as Highly Potent Ligands of Central Benzodiazepine Receptors 379
Anionic Polymerization of a Benzofulvene Monomer Leading to a Thermoreversible π-Stacked Polymer. Studies in Macromolecular and Aggregate Structure 349
A Click Chemistry-Based “Grafting Through” Approach to the Synthesis of a Biorelevant Polymer Brush 334
A Nanocomposite Material Formed by Benzofulvene Polymer Nanoparticles Loaded with a Potent 5-HT3 Receptor Antagonist (CR3124) 316
A Non-Peptide NK1 Receptor Agonist Showing Subpicomolar Affinity 295
Combining Spontaneous Polymerization and Click Reactions for the Synthesis of Polymer Brushes: A “Grafting Onto” Approach 261
Bivalent Ligands for the Serotonin 5-HT3 Receptor 258
Characterization of Quinoline Derivatives. II. 7-(4-methyl-1-piperazinyl)-6H-[1]benzopyrano[3,4-c]quinoline 246
Characterization of persistent intramolecular C-H⋅⋅⋅X(N,O) bonds in solid state and solution 243
Synthesis and Spontaneous Polymerization of Oligo(ethylene glycol)-Conjugated Benzofulvene Macromonomers. A Polymer Brush Forming a Physical Hydrogel 241
Novel Analgesic/Anti-inflammatory Agents: 1,5-Diarylpyrrole Nitrooxyalkyl Ethers and Related Compounds as Cyclooxygenase-2 Inhibiting Nitric Oxide Donors 235
5-HT and Benzodiazepine Receptor Ligands. III. Synthesis and Receptor Affinities of 1,2,4,-Triazolo[4',3':1,6]pyridazino[4,5-b]quinoline and 2,3-Dihydro-9-phenyl-1H-pyrrolo[3,4-b]quinoline-1-one Derivatives 233
Design, Synthesis, and Biological Evaluation of AT1 Angiotensin II Receptor Antagonists Based on the Pyrazolo[3,4-b]pyridine and related Heteroaromatic Bicyclic Systems 230
6-(1-Piperazinyl)-7H-indeno[2,1-c]quinoline Derivatives with High Affinity and Selectivity for 5-HT3 Serotonin Sites 229
Design, Synthesis, and Structure-Affinity Relationship Studies in NK1 Receptor Ligands Based on Azole-Fused Quinolinecarboxamide Moieties 225
Amidine, Thiourea and Guanidine Derivatives of 2-Aminobenzothiazoles and Aminobenzothiazines, Novel Pharmacological Agents for the Treatment of Neurodegenerative Pathologies 225
The Interactions of the 5-HT3 Receptor with Quipazine-Like Arylpiperazine Ligands. The Journey Track at the End of the First Decade of the Third Millennium 224
Physicochemical and biopharmaceutical characterization of endo-2-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-2,3-dihydro-1H-benz[e]isoindol-1-one (CR3124) a novel potent 5-HT3 receptor antagonist 221
Phenylindenone isomers as divergent modulators of p38α MAP kinase 216
Design, Synthesis, and Preliminary Biological Evaluation of Pyrrolo[3,4-c]quinolin-1-one and Oxoisoindoline Derivatives as Aggrecanase Inhibitors 216
Structural Manipulation of Benzofulvene Derivatives Showing Spontaneous Thermoreversible Polymerization. Role of the Substituents in the Modulation of Polymer Properties 215
Characterization of Quinoline Derivatives. I. 6,7-Dihydro-8-(4-methyl-1-piperazinyl)[1]benzoxepino[4,5-c]quinoline 0.13-Hydrate 209
11C-Labelling of the 5-HT3 Antagonist VC125 for PET Distribution Studies 209
Synthesis and characterization of charge-transporting π-stacked polybenzofulvene derivatives 202
Synthesis and Structure-Activity Relationship Studies in Translocator Protein Ligands Based on a Pyrazolo[3,4-b]quinoline Scaffold 198
Reversible polymerization techniques leading to π-stacked polymers 194
Synthesis of 6-(4-Methyl-1-piperazinyl)-7H-indeno[2,1-c]quinoline Derivatives as Potential 5-HT Receptor Ligands 191
Novel and Highly Potent 5-HT3 Receptor Agonists Based on a Pyrroloquinoxaline Structure 190
Synthesis, Biological Evaluation, and Quantitative Receptor Docking Simulations of 2-Acylaminoethyl-1,4-benzodiazepines as novel Tifluadom-Like Ligands with High Affinity and Selectivity for k-Opioid Receptors 190
Synthesis and biological evaluation of amidine, guanidine, and thiourea derivatives of 2-amino(6-trifluoromethoxy)benzothiazole as neuroprotective agents potentially useful in brain diseases 189
Synthesis of 2-Substituted-2,3-dihydro-9-phenyl-1H-pyrrolo[3,4-b]quinolin-3-ones as Potential Peripheral Benzodiazepine-receptor Ligands 188
Synthesis of 6,7-Dihydro-8-(4-methyl-1-piperazinyl)-[1]benzoxepino[4,5-c]quinoline as Potential 5-HT3 Receptor Ligand 187
Novel Basic Derivatives of Benz[e]isoindol-1-ones and Pyrrolo[3,4-c]quinolin-1-ones with 5-HT3 Antagonistic Activity, their Preparation and their Therapeutic Use 186
Heterotricyclic Amide Derivatives as Neurokinin-1 (NK1) Receptor Ligands 185
Mapping and Fitting the Peripheral Benzodiazepine Receptor Binding Site by Carboxamide Derivatives. Comparison of Different Approaches to Quantitative Ligand-Receptor Interaction Modeling 185
Synthesis, Labeling, and Biological Evaluation of Halogenated 2-Quinolinecarboxamides as Potential Radioligands for the Visualization of Peripheral Benzodiazepine Receptors 183
Non-peptide NK1 receptor ligands based on the 4-phenylpyridine moiety 183
Further studies on imidazo[4,5-b]pyridine AT1 angiotensin II receptor antagonists. Effects of the transformation of the 4-phenylquinoline backbone into 4-phenylisoquinolinone or 1-phenylindene scaffolds 182
Structure-Activity Relationships in Carboxamide Derivatives Based on the Targeted Delivery of Radionuclides and Boron Atoms by Means of Peripheral Benzodiazepine Receptor Ligands 181
New red-shifted coelenterazine analogues with an extended electronic conjugation 181
Synthesis and Characterization of a New Benzofulvene Polymer Showing a Thermoreversible Polymerization Behavior 179
Molecular Basis of Peripheral vs Central Benzodiazepine Receptor Selectivity in a New Class of Peripheral Benzodiazepine Receptor Ligands Related to Alpidem 179
Structure-Property Relationships in Densely Grafted π-Stacked Polymers 178
Characterization and Differentiation of Heterocyclic Isomers. Part 2. Mass Spectrometry and Molecular Orbital Calculations on Pyrrolo[1,2-a][1,4]benzodiazepin-4-one, -6-one, -4,6-dione 178
Mapping the Peripheral Benzodiazepine Receptor Binding Site by Conformationally Restrained Derivatives of 1-(2-Chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide (PK11195) 177
Synthesis of 1,2,4,-Triazolo[4',3':1,6]pyridazino[4,5-b]quinoline Derivatives 177
Characterization of Quinoline Derivatives. Part 3. Mass Spectrometry and X-ray Crystallography of Biologically Interesting Arylquinolines 176
Multivalent Supramolecular Dendrimer-Based Drugs 171
New Insight into the Central Benzodiazepine Receptor-Ligand Interactions: Design, Synthesis, Biological Evaluation, and Molecular Modeling of 3-Substituted 6-Phenyl-4H-imidazo[1,5-a][1,4]benzodiazepines and Related Compounds 169
null 169
Determination of a novel angiotensin-AT1 Antagonist CR3210, in biological samples by HPLC 168
Ethyl 8-Fluoro-6-(3-nitrophenyl)-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate as Novel, Highly Potent, and Safe Antianxiety Agent 165
CoMFA Analysis of Ligands of the Mitochondrial Benzodiazepine Receptor: A Versatile Tool for the Design of New Lead Compounds 162
Hyaluronan derivatives bearing variable densities of ferulic acid residues 162
Further Studies on the Interaction of 5-Hydroxytryptamine3 (5-HT3) Receptor with Arylpiperazine Ligands. Development of a New 5-HT3 Receptor Ligand Showing Potent Acetylcholinesterase Inhibitory Properties 161
Design, Synthesis, Structural Studies, Biological Evaluation, and Computational Simulations of Novel Potent AT1 Angiotensin II Receptor Antagonists Based on the 4-Phenylquinoline Structure 160
Molecular Structure and Dynamics of Some Potent 5-HT3 Receptor Antagonists. Insight into the Interaction with the Receptor 159
Synthesis, Resolution, and Absolute Configuration of Two Novel and Selective Cyclooxygenase-2 Inhibitors Based on 1,5-Diarylpyrrole Structure 158
Synthesis and Biological Characterization of Novel 2-Quinolinecarboxamide Ligands of the Peripheral Benzodiazepine Receptors Bearing Technetium-99m or Rhenium 156
Structure–affinity relationship studies on arylpiperazine derivatives related to quipazine as serotonin transporter ligands. Molecular basis of the selectivity SERT/5-HT3 receptor 155
Novel potent 5-HT3 receptor ligands based on the pyrrolidone structure: synthesis, biological evaluation, and computational rationalization of the ligand-receptor interaction modalities 154
Synthesis, Biological Evaluation and Receptor Docking Simulations of 2-[(Acylamino)ethyl]-1,4-benzodiazepines as k-Opioid Receptor Agonists Endowed with Antinociceptive and Antiamnestic Activity 151
Novel polybenzofulvene derivatives: synthesis and uses thereof 151
Synthesis and structure-activity relationship studies in peripheral benzodiazepine receptor ligands related to alpidem 149
Novel Potent 5-HT3 Receptor Ligands Based on the Pyrrolidone Structure. Effects of the Quaternization of the Basic Nitrogen on the Interaction with 5-HT3 Receptor 146
Labeling and Evaluation of N-[11C]Methylated Quinoline-2-carboxamide as Potential Radioligands for Visualization of Peripheral Benzodiazepine Receptors 141
Evaluation of Three Quinoline-Carboxamide Derivatives as Potential Radioligands for the in Vivo PET Imaging of Neurodegeneration 140
Novel Potent and Selective Central 5-HT3 Receptor Ligands Provided with Different Intrinsic Efficacy. 2. Molecular Basis of the Intrinsic Efficacy of Arylpiperazine Derivatives at the Central 5-HT3 Receptors 140
Synthesis and Benzodiazepine Receptors Affinity of 2,3-Dihydro-9- phenyl-1H-pyrrolo[3,4-b]quinolin-1-one and 3-Carbethoxy-4-phenylquinoline Derivatives 138
Synthesis and 5-HT Receptors Binding Studies of Some 3-Substituted-2-(4-methyl-1-piperazinyl)-4-phenylquinolines 136
Imidazo[1,2-a]pyrazin-3(7H)-one Derivatives Bearing a New Electron-Rich Structure. 134
The Interaction of the 5-HT3 Receptor with Arylpiperazine, Tropane, and Quinuclidine Ligands 132
Reversible Polymerization Techniques Leading to pi-Stacked Polymers 132
Novel Potent and Selective 5-HT3 Receptor Antagonists Based on Arylpiperazine Skeleton: Synthesis, Structure, Biological Activity and CoMFA Studies 130
Enzymatic and Molecular Modeling Studies of 5-HT3 Receptor Ligands Based on Pyrroloquinoline Structure and Provided with Acetylcholinesterase Inhibitory Activity 127
π-Stacked polymers in drug delivery applications 125
Synthesis of 4-Substituted-1,2,3,4-tetrahydro-11-phenyl-5H-azepino[3,4-b]quinolin-5-one as Potential Peripheral Benzodiazepine-receptor Ligands 122
Synthesis of the Novel [11C]-Labelled Quinoline Carboxamides: Analogues of PK-11195 as Putative Radioligands for PET Studies of Peripheral Type Benzodiazepine Receptors 120
Synthesis and 5-HT-Receptors Affinity of Some 4-Phenylquinoline Derivatives 114
Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. I. Mapping the central 5-HT3 recceptor binding site by arylpiperazine derivatives 114
Synthesis and Receptor Binding Studies of 2-Functionalized 1,4-Benzodiazepine Derivatives as Potential Metaclazepam-like Antianxiety Agents 112
Synthesis of 2,10-Diphenyl-2H-pyridazino[4,5-b]quinolin-1-one and 2,3-Dihydro-9-phenyl-2-phenylamino-1H-pyrrolo[3,4-b]quinolin-1-one Derivatives as Peripheral-type Benzodiazepine Receptors Ligands 103
Totale 15.274
Categoria #
all - tutte 44.997
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.997


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021246 0 0 0 0 0 0 0 0 0 68 111 67
2021/2022997 68 151 31 174 38 14 54 25 39 104 86 213
2022/20231.420 90 108 188 210 135 296 35 106 135 36 56 25
2023/2024924 26 9 103 36 31 277 327 30 0 1 4 80
2024/20251.907 32 114 172 81 277 84 18 90 119 77 206 637
2025/20264.028 354 715 657 511 768 136 440 99 143 205 0 0
Totale 15.274